Supplemental Annuity Collective Trust (SACT) of New Jersey’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$755K Sell
13,098
-686
-5% -$39.4K 0.19% 99
2026
Q1
$836K Sell
13,784
-11,216
-45% -$654K 0.24% 82
2025
Q4
$1.35M Hold
25,000
0.35% 62
2025
Q3
$1.13M Hold
25,000
0.3% 78
2025
Q2
$1.16M Hold
25,000
0.33% 68
2025
Q1
$1.52M Hold
25,000
0.48% 48
2024
Q4
$1.41M Hold
25,000
0.42% 53
2024
Q3
$1.29M Hold
25,000
0.38% 65
2024
Q2
$1.04M Hold
25,000
0.32% 76
2024
Q1
$1.36M Hold
25,000
0.42% 57
2023
Q4
$1.28M Hold
25,000
0.45% 58
2023
Q3
$1.45M Hold
25,000
0.55% 35
2023
Q2
$1.6M Hold
25,000
0.57% 34
2023
Q1
$1.73M Hold
25,000
0.68% 25
2022
Q4
$1.8M Hold
25,000
0.75% 27
2022
Q3
$1.78M Hold
25,000
0.78% 21
2022
Q2
$1.93M Hold
25,000
0.77% 21
2022
Q1
$1.83M Hold
25,000
0.6% 30
2021
Q4
$1.56M Hold
25,000
0.48% 47
2021
Q3
$1.48M Sell
25,000
-12,000
-32% -$790K 0.49% 50
2021
Q2
$2.47M Hold
37,000
0.8% 20
2021
Q1
$2.34M Hold
37,000
0.81% 21
2020
Q4
$2.29M Hold
37,000
0.85% 20
2020
Q3
$2.23M Hold
37,000
0.93% 17
2020
Q2
$2.18M Hold
37,000
0.99% 16
2020
Q1
$2.06M Hold
37,000
1.14% 14
2019
Q4
$2.38M Buy
37,000
+15,000
+68% +$859K 0.98% 17
2019
Q3
$1.12M Hold
22,000
0.51% 46
2019
Q2
$998K Buy
22,000
+1,000
+5% +$46.6K 0.44% 55
2019
Q1
$1M Sell
21,000
-5,000
-19% -$249K 0.45% 65
2018
Q4
$1.35M Hold
26,000
0.69% 33
2018
Q3
$1.61M Hold
26,000
0.67% 29
2018
Q2
$1.44M Buy
26,000
+2,000
+8% +$108K 0.62% 39
2018
Q1
$1.52M Hold
24,000
0.66% 31
2017
Q4
$1.47M Buy
24,000
+2,000
+9% +$125K 0.62% 35
2017
Q3
$1.4M Buy
22,000
+2,000
+10% +$117K 0.62% 43
2017
Q2
$1.11M Hold
20,000
0.5% 62
2017
Q1
$1.09M Sell
20,000
-5,211
-21% -$286K 0.49% 68
2016
Q4
$1.47M Hold
25,211
0.7% 41
2016
Q3
$1.36M Hold
25,211
0.67% 43
2016
Q2
$1.85M Hold
25,211
0.93% 26
2016
Q1
$1.61M Hold
25,211
0.82% 29
2015
Q4
$1.73M Hold
25,211
0.88% 29
2015
Q3
$1.49M Hold
25,211
0.79% 32
2015
Q2
$1.68M Hold
25,211
0.8% 31
2015
Q1
$1.63M Hold
25,211
0.76% 34
2014
Q4
$1.49M Hold
25,211
0.7% 38
2014
Q3
$1.29M Hold
25,211
0.63% 41
2014
Q2
$1.22M Hold
25,211
0.59% 44
2014
Q1
$1.31M Hold
25,211
0.65% 38
2013
Q4
$1.34M Hold
25,211
0.66% 39
2013
Q3
$1.17M Hold
25,211
0.63% 40
2013
Q2
$1.13M Buy
+25,211
New +$1.09M 0.64% 38

Other funds holding BMY

Supplemental Annuity Collective Trust (SACT) of New Jersey's BMY Position: Q2 2026 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q2 2026, selling an estimated $39.4K and leaving 13,098 shares worth $755K. The position accounts for 0.19% of the portfolio, ranked #99.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.47M in Q2 2021. 1,973 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Supplemental Annuity Collective Trust (SACT) of New Jersey held 13,098 shares of Bristol-Myers Squibb worth $755K as of Q2 2026.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey sold 686 Bristol-Myers Squibb shares in Q2 2026, an estimated $39.4K.
  • Bristol-Myers Squibb made up 0.19% of Supplemental Annuity Collective Trust (SACT) of New Jersey's portfolio in Q2 2026, its #99 holding.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey's Bristol-Myers Squibb position peaked at $2.47M in Q2 2021.
  • 1,973 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q2 2026, filed 27 Jul 2026.